NO161177C - Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere. - Google Patents

Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.

Info

Publication number
NO161177C
NO161177C NO852589A NO852589A NO161177C NO 161177 C NO161177 C NO 161177C NO 852589 A NO852589 A NO 852589A NO 852589 A NO852589 A NO 852589A NO 161177 C NO161177 C NO 161177C
Authority
NO
Norway
Prior art keywords
tioeters
preparation
therapeutic active
analogy procedure
analogy
Prior art date
Application number
NO852589A
Other languages
English (en)
Other versions
NO852589L (no
NO161177B (no
Inventor
Andreas Von Sprecher
Ivan Ernest
Alan Joseph Main
Andreas Beck
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO852589L publication Critical patent/NO852589L/no
Publication of NO161177B publication Critical patent/NO161177B/no
Publication of NO161177C publication Critical patent/NO161177C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO852589A 1984-06-28 1985-06-27 Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere. NO161177C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH311584 1984-06-28
CH61785 1985-02-12

Publications (3)

Publication Number Publication Date
NO852589L NO852589L (no) 1985-12-30
NO161177B NO161177B (no) 1989-04-03
NO161177C true NO161177C (no) 1989-07-12

Family

ID=25685130

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852589A NO161177C (no) 1984-06-28 1985-06-27 Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.

Country Status (13)

Country Link
US (1) US4649215A (no)
EP (1) EP0170048B1 (no)
AU (1) AU4422985A (no)
CA (1) CA1276393C (no)
DE (1) DE3582527D1 (no)
DK (1) DK291485A (no)
ES (1) ES8606260A1 (no)
FI (1) FI852527L (no)
GR (1) GR851563B (no)
IL (1) IL75620A (no)
NO (1) NO161177C (no)
NZ (1) NZ212573A (no)
PT (1) PT80716B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6257A (ja) * 1985-03-19 1987-01-06 Green Cross Corp:The 含硫アミン−脂肪酸のアミド誘導体
US4808572A (en) * 1985-12-06 1989-02-28 Ciba-Geigy Corporation α-Hydroxy thioethers
US4785004A (en) * 1985-12-23 1988-11-15 Ciba-Geigy Corporation Aromatic thioethers
KR870011086A (ko) * 1986-05-29 1987-12-19 벤자민 에프. 램버트 포스포리파제 a₂억제제 및 그의 합성방법
US5149717A (en) * 1988-03-29 1992-09-22 Ciba-Geigy Corporation Alkanophenones useful for treating allergies
EP0419410A3 (en) * 1989-09-19 1991-08-14 Ciba-Geigy Ag Alkanophenones
DE4228455A1 (de) * 1992-08-26 1994-09-15 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Thiolen und/oder Thiolderivaten
US5464754A (en) * 1993-08-17 1995-11-07 The Regents Of The University Of California Assay and substrate for arachidonoyl-specific phospholipase A2
JP2004533407A (ja) * 2000-10-23 2004-11-04 ジ・アリゾナ・ディジーズ・コントロール・リサーチ・コミッション タンパク質プレニル化の調節に基づく抗癌剤
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US11351127B2 (en) 2016-09-21 2022-06-07 Avexxin As Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12241T1 (de) * 1981-03-03 1985-04-15 Lilly Industries Ltd Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
DK130984A (da) * 1983-03-07 1984-09-08 Smithkline Beckman Corp Leukotrien-antagonister
EP0123543B1 (en) * 1983-04-21 1988-02-03 Merck Frosst Canada Inc. Leukotriene antagonists, their production and use and compositions containing them

Also Published As

Publication number Publication date
FI852527L (fi) 1985-12-29
GR851563B (no) 1985-11-25
US4649215A (en) 1987-03-10
NO852589L (no) 1985-12-30
DE3582527D1 (en) 1991-05-23
PT80716A (de) 1985-07-01
EP0170048A3 (en) 1988-08-10
DK291485A (da) 1985-12-29
AU4422985A (en) 1986-01-02
NO161177B (no) 1989-04-03
FI852527A0 (fi) 1985-06-26
CA1276393C (en) 1990-11-13
EP0170048B1 (de) 1991-04-17
IL75620A0 (en) 1985-10-31
IL75620A (en) 1989-05-15
ES544534A0 (es) 1986-04-16
PT80716B (de) 1987-03-31
ES8606260A1 (es) 1986-04-16
EP0170048A2 (de) 1986-02-05
NZ212573A (en) 1989-03-29
DK291485D0 (da) 1985-06-27

Similar Documents

Publication Publication Date Title
NO162022C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive cefemderivater.
NO164165C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO166327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
NO871267L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO166080C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,8-trifluorkinoliner.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO163570C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO164417C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive iminothiazolidinderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.